US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

28.88

-0.0814-0.28%

Post-market: 28.82-0.0628-0.22%19:30 EDT

Volume:3K

Turnover:72.76K

Market Cap:30.32M

PE:- -

High:29.19

Open:29.19

Low:28.82

Close:28.96

52wk High:33.59

52wk Low:23.00

Shares:1.05M

Float Shares:1.05M

Volume Ratio:0.55

T/O Rate:0.24%

Dividend:0.07

Dividend Rate:0.25%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

IQVIA Holdings Completes $2 Billion Senior Notes Issuance

IQVIA Unit Issues USD 2 Billion of 6.375% Senior Notes Due 2034

Centene Corp. Stock Underperforms Wednesday When Compared to Competitors

Hims & Hers CFO Oluyemi Okupe Sells 29,277 Common Shares for $876,846.15

American Diversified Holdings Unit GlucoGuard Publishes Investor Deck for FDA Research Funding

Gartner Inc. Stock Outperforms Competitors Despite Losses on the Day

Centene Corp. Stock Underperforms Tuesday When Compared to Competitors

Wall Street Analysts Are Bullish on Top Healthcare Picks

Oscar Health initial stock reaction on CMS news overdone, says Raymond James

Cboe data suggests bullish flow in Hims and Hers Health with shares up 3.56%

Scienture Partners with Distributor to Sell Rezenopy Naloxone Spray to 2,000 US Opioid Treatment Clinics

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Avantor (AVTR)

Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal

Tempus Extends Data Licensing Partnership with Recursion Through November 2029

Tempus AI, Recursion Extend Data License, Amend Fee Structure

MT Newswires Live

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Recursion, Tempus Expand AI and RNA Collaboration Agreements

Tempus AI, Recursion extend data license agreement, enter new license agreement

Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm

THOMSON REUTERS

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/HEAL/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HEAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","market":"US","secType":"STK","nameCN":"Global X HealthTech ETF","latestPrice":28.8828,"timestamp":1790971200000,"preClose":28.9642,"halted":0,"volume":2512,"hourTrading":{"tag":"盘后","latestPrice":28.82,"preClose":28.8828,"latestTime":"19:30 EDT","volume":14,"amount":403.434,"timestamp":1790983804987,"change":-0.0628,"changeRate":-0.002174,"amplitude":0},"delay":0,"changeRate":-0.0028103658999731438,"floatShares":1049843,"shares":1049843,"eps":0,"marketStatus":"Market Closed","change":-0.0814,"latestTime":"10-02 16:00:00 EDT","open":29.19,"high":29.19,"low":28.82,"amount":72755.887472,"amplitude":0.012774,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":28.9642,"sharesOutstanding":1329868,"nav":28.94,"aum":30384361.48,"dividendRate":0.002451,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":29.05,"preClose":28.9642,"latestTime":"09:29 EDT","volume":16,"amount":464.8,"timestamp":1790947790009,"change":0.0858,"changeRate":0.002962,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":28.82,"preClose":28.8828,"latestTime":"19:30 EDT","volume":14,"amount":403.434,"timestamp":1790983804987,"change":-0.0628,"changeRate":-0.002174,"amplitude":0},"volumeRatio":0.545754771016126,"impliedVol":0.0746,"impliedVolPercentile":0.3705},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HEAL\",,,,,undefined,":{"symbol":"HEAL","floatShares":1049843,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.545754771016126,"shares":1049843,"dividePrice":0.0708,"high":29.19,"amplitude":0.012774,"preClose":28.9642,"low":28.82,"week52Low":23,"pbRate":"--","week52High":33.59,"institutionHeld":0,"latestPrice":28.8828,"eps":0,"divideRate":0.002451,"volume":2512,"delay":0,"ttmEps":0,"open":29.19,"prevYearClose":29.215,"prevWeekClose":29.32,"prevMonthClose":29.5116,"prevQuarterClose":29.5116,"fiveDayClose":29.32,"twentyDayClose":29.6302,"sixtyDayClose":28.745},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HEAL\",params:#limit:5,,,undefined,":[{"date":"2025-12-30","symbol":"HEAL","amount":0.071843,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"HEAL","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":3,"toFactor":1,"ratio":3},{"date":"2025-06-27","symbol":"HEAL","amount":0.00815,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X HealthTech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HEAL\",market:\"US\",,,undefined,":[{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00815,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.071843,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HEAL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HEAL\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669851431","title":"IQVIA Holdings Completes $2 Billion Senior Notes Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2669851431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669851431?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:30","pubTimestamp":1790199043,"startTime":"0","endTime":"0","summary":"IQVIA Holdings ( ($IQV) ) has provided an announcement. On September 23, 2026, IQVIA Inc., a subsidiary of IQVIA Holdings, completed a $2 billion i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iqvia-holdings-completes-2-billion-senior-notes-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iqvia-holdings-completes-2-billion-senior-notes-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1201861165.SGD","LU0528227936.USD","LU1201861249.SGD","LU0130518102.USD","LU1261432733.SGD","LU0130103400.USD","LU0648000940.SGD","BK4530","LU1791710582.SGD","HEAL","EKG","LU0477156797.USD","BK4585","BK4588","LU1989764748.USD","LU0980610538.SGD","LU1989764664.SGD","LU0198837287.USD","LU0648001328.SGD","BK4121","LU0130517989.USD","LU0130102774.USD","IQV","LU0882574055.USD","LU1791710400.SGD","LU0477156953.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669439508","title":"IQVIA Unit Issues USD 2 Billion of 6.375% Senior Notes Due 2034","url":"https://stock-news.laohu8.com/highlight/detail?id=2669439508","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669439508?lang=en_us&edition=fundamental","pubTime":"2026-09-24 05:03","pubTimestamp":1790197423,"startTime":"0","endTime":"0","summary":"IQVIA unit issues USD 2 billion of 6.375% senior notes due 2034IQVIA issued USD 2 billion of 6.375% senior notes due 2034 through subsidiary IQVIA Inc.Proceeds earmarked to redeem Senior 5.000% Notes ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL4d8g1W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFNL","LU1989764664.SGD","LU0130103400.USD","LU0170899867.USD","LU0882574055.USD","LU0528227936.USD","LU1894683264.USD","LU2596442595.SGD","LU2237438978.USD","LU0648000940.SGD","LU1201861249.SGD","USB","LU0477156797.USD","LU0130517989.USD","LU1201861165.SGD","LU1989764748.USD","LU0198837287.USD","BK4559","LU1791710582.SGD","BK4585","HEAL","IQV","IE00BFXG1179.USD","LU0648001328.SGD","LU1791710400.SGD","BK4504","BK4588","BK4121","BK4207","EKG","LU0130518102.USD","IAT","LU0980610538.SGD","BK4530","LU0477156953.USD","LU1883839398.USD","LU0130102774.USD","LU1261432733.SGD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669342439","title":"Centene Corp. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669342439","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669342439?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:57","pubTimestamp":1790197020,"startTime":"0","endTime":"0","summary":"DJ Centene Corp. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Centene Corp.  slipped 1.93% to $62.08 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.75% to 7,706.03 and Dow Jones Industrial Average  falling 0.68% to 51,511.59.This was the stock's fourth consecutive day of losses.Centene Corp. closed 10.84% short of its 52-week high of $69.63, which the company achieved on September 14th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as HCA Healthcare Inc.  fell 0.37% to $436.48, IQVIA Holdings Inc.  fell 0.83% to $267.86, and Labcorp Holdings Inc.  fell 2.43% to $303.98.Data source: Dow Jones Market Data, FactSet. Data compiled September 23, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","LU1150488218.USD","LU0859254822.USD","LU0868494617.USD","HEAL","LU0477156797.USD","BK4585","LU2065169927.USD","LU1084165304.USD","IE0034235188.USD","LU1201861249.SGD","BK4185","LU0130517989.USD","BK4588","HCA","LU0203345920.USD","CNC","LU1489326972.SGD","BK4154","LU0985489474.SGD","LU1201861165.SGD","LU0433182093.SGD","LU2355687059.USD","LU0198837287.USD","LU0310800379.SGD","LU0742534661.SGD","LU1989764664.SGD","LU0878866978.SGD","LU0130103400.USD","IHF","LU2065171311.SGD","SG9999014039.USD","CNCG","LU0310799852.SGD","LU1989771016.USD","IE00B775SV38.USD","BK4550","LU0203347892.USD","LU2065171402.SGD","LU0251142724.SGD","LU2362541273.HKD","LH","IQV","LU0477156953.USD","LU0187121727.USD","LU0528227936.USD","LU2362541513.USD","EKG","LU2065170008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669436685","title":"Hims & Hers CFO Oluyemi Okupe Sells 29,277 Common Shares for $876,846.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2669436685","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669436685?lang=en_us&edition=fundamental","pubTime":"2026-09-24 04:17","pubTimestamp":1790194672,"startTime":"0","endTime":"0","summary":"Hims & Hers CFO Oluyemi Okupe sells 29,277 common shares for $876,846.15Hims & Hers Health CFO Oluyemi Okupe sold 29,277 Class A shares on Sept. 22 at USD 29.95.Okupe exercised options for 14,000 shar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL8NjRcH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMC","GLAM","HEAL","HIMS","THNR","HIYY","HIMZ","HIMY","BK4196","HMYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669861644","title":"American Diversified Holdings Unit GlucoGuard Publishes Investor Deck for FDA Research Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2669861644","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669861644?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:00","pubTimestamp":1790168434,"startTime":"0","endTime":"0","summary":"American Diversified Holdings unit GlucoGuard publishes investor deck for FDA research fundingAmerican Diversified Holdings published a GlucoGuard investor deck focused on funding research required fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL3l1n8P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BMPRXR70.SGD","ADHC","LU0354030438.USD","LU1323610961.USD","EKG","LU2433249047.HKD","IE00BMPRXN33.USD","LU2210149790.SGD","LU2210150020.SGD","BK4551","BK4534","BK4585","HEAL","LU1923622614.USD","LU2125909593.SGD","GB00BDT5M118.USD","BK4167","LU0266013472.USD","LU2095319765.USD","BK4082","BK4588","LU0354030511.USD","BK4548","DXCM","BK4504","LU2125909247.SGD","LU2211815571.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669312718","title":"Gartner Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2669312718","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669312718?lang=en_us&edition=fundamental","pubTime":"2026-09-23 05:13","pubTimestamp":1790111580,"startTime":"0","endTime":"0","summary":"DJ Gartner Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gartner Inc.  slid 2.49% to $178.75 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average  falling 0.36% to 51,863.69.This was the stock's sixth consecutive day of losses.Gartner Inc. closed 32.76% below its 52-week high of $265.85, which the company achieved on September 26th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Trade Desk Inc. Cl A  fell 5.04% to $13.18, IQVIA Holdings Inc.  rose 0.08% to $270.09, and Omnicom Group Inc.  fell 0.33% to $75.34.Trading volume  remained 428,589 below its 50-day average volume of 1.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0742537680.HKD","LU1814569148.SGD","LU2517655028.SGD","LU0154245673.USD","LU1509826696.USD","LU0731783394.SGD","LU1720051108.HKD","LU0321505868.SGD","LU0772969993.USD","IQV","LU0198837287.USD","HEAL","LU0648000940.SGD","LU1791710582.SGD","LU0348723411.USD","RSPC","LU1201861249.SGD","LU0477156953.USD","BK4548","BK4121","EKG","LU2517655291.USD","LU0980610538.SGD","LU0130102774.USD","LU1599440770.SGD","OMC","TTD","BK4009","LU1989764664.SGD","BK4530","LU1201861165.SGD","LU0648001328.SGD","LU0130518102.USD","BK4023","LU1481011911.USD","LU2362541513.USD","TTDU","LU1791710400.SGD","LU2362541273.HKD","LU0130103400.USD","LU2357305700.SGD","LU1720051017.SGD","IT","BK4134","BK4588","LU2517655374.HKD","IE00BFXG1179.USD","LU0154245756.USD","LU0882574055.USD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669127397","title":"Centene Corp. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669127397","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669127397?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:55","pubTimestamp":1790110500,"startTime":"0","endTime":"0","summary":"DJ Centene Corp. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Centene Corp.  slid 2.60% to $63.30 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  remaining mostly unchanged at 7,764.64 and the Dow Jones Industrial Average  falling 0.36% to 51,863.69.This was the stock's third consecutive day of losses.Centene Corp. closed 9.09% short of its 52-week high of $69.63, which the company reached on September 14th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as HCA Healthcare Inc.  rose 2.85% to $438.12, IQVIA Holdings Inc.  rose 0.08% to $270.09, and Labcorp Holdings Inc.  fell 2.94% to $311.54.Data source: Dow Jones Market Data, FactSet. Data compiled September 22, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU1791710582.SGD","LU0878866978.SGD","SG9999014021.USD","LH","LU0742534661.SGD","LU1267930490.SGD","LU2362540622.SGD","LU2362541513.USD","LU1489326972.SGD","LU1150488135.SGD","LU1791710400.SGD","BK4196","LU0198837287.USD","LU2355687059.USD","LU0048573561.USD","LU2237438978.USD","LU1059921491.USD","LU0130103400.USD","LU1201861165.SGD","LU2362541273.HKD","IQV","LU0433182093.SGD","LU0251142724.SGD","CNC","BK4121","SG9999014013.SGD","LU0477156797.USD","SG9999014039.USD","HEAL","LU0868494617.USD","LU1291159041.SGD","IHF","LU0128525929.USD","EKG","LU0310800379.SGD","BK4154","LU2357627491.SGD","IE0034235188.USD","LU0985489474.SGD","LU0211327993.USD","LU0882574055.USD","CNCG","LU0648000940.SGD","LU1119994496.HKD","HCA","BK4185","LU0980610538.SGD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669612405","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669612405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669612405?lang=en_us&edition=fundamental","pubTime":"2026-09-23 03:40","pubTimestamp":1790106013,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compass Therapeutics (CMPX) and Oscar Health (OSCR) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-346?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-346?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OSCG","CMPX","OSCR","BK4551","HEAL","OSCX","BK4162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124149","title":"Oscar Health initial stock reaction on CMS news overdone, says Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124149","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669124149?lang=en_us&edition=fundamental","pubTime":"2026-09-23 03:35","pubTimestamp":1790105709,"startTime":"0","endTime":"0","summary":"Raymond James reiterated an Outperform rating and $42 price target on Oscar Health (OSCR) after the Centers for Medicare & Medicaid Services announ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oscar-health-initial-stock-reaction-on-cms-news-overdone-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oscar-health-initial-stock-reaction-on-cms-news-overdone-says-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSCG","OSCX","BK4551","OSCR","BK4162","HEAL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669386126","title":"Cboe data suggests bullish flow in Hims and Hers Health with shares up 3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669386126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669386126?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:25","pubTimestamp":1790094312,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Hims and Hers Health (HIMS), with shares up $1.04, or 3.56%, near $30.39. Options volume running well above aver...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-3-56-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-hims-and-hers-health-with-shares-up-3-56-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIMY","THNR","HMYY","GLAM","BK4196","HIMZ","HIYY","HIMS","HEAL","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669714483","title":"Scienture Partners with Distributor to Sell Rezenopy Naloxone Spray to 2,000 US Opioid Treatment Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2669714483","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669714483?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:15","pubTimestamp":1790079323,"startTime":"0","endTime":"0","summary":"Scienture partners with distributor to sell REZENOPY naloxone spray to 2,000 US opioid treatment clinicsScienture Holdings entered an exclusive sales, marketing, distribution deal for REZENOPY naloxon","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL8Z6Dt7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130103400.USD","LU0648000940.SGD","BK4121","IE00B64PRP62.GBP","IQV","LU2210149790.SGD","IE00BGHQF748.EUR","LU1201861165.SGD","IE00BQXX3D17.EUR","SG9999014021.USD","HEAL","LU0882574055.USD","LU1791710400.SGD","SG9999014039.USD","LU1989764748.USD","SG9999014005.SGD","EKG","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU1989764664.SGD","LU0648001328.SGD","NDAQ","BK4112","LU1791710582.SGD","LU0477156953.USD","BK4167","LU0130518102.USD","LU0980610538.SGD","SCNX","LU0130102774.USD","BK4585","LU0198837287.USD","SG9999014013.SGD","BK4588","LU0130517989.USD","LU1261432733.SGD","LU0314104364.USD","BK4530","LU2210150020.SGD","LU1201861249.SGD","LU0477156797.USD","LU2095319765.USD","LU0528227936.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110468","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Avantor (AVTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669110468?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:10","pubTimestamp":1790068204,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tempus AI, Inc. Class A (TEM) and Avantor (AVTR). Tempus AI, Inc....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-tempus-ai-inc-class-a-tem-and-avantor-avtr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-tempus-ai-inc-class-a-tem-and-avantor-avtr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","LU1861558580.USD","HEAL","TEMC","ARKG","LU0006061336.USD","TEM","AVTR","BK4611","TEMT","BK4613","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162636","title":"Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162636","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162636?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:18","pubTimestamp":1790007493,"startTime":"0","endTime":"0","summary":"Recursion licenses TxFM RNA foundation model to Tempus AI for oncology use in USD 12 million dealRecursion Pharmaceuticals expanded its data partnership with Tempus AI, extending the term to six years","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL7Y7sX8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4121","TEM","BK4548","BK4139","BK4613","TEMC","BK4609","RXRX","LU1861559042.SGD","BK4611","BK4539","ARKG","HEAL","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669162688","title":"Tempus Extends Data Licensing Partnership with Recursion Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669162688","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669162688?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:17","pubTimestamp":1790007444,"startTime":"0","endTime":"0","summary":"Tempus extends data licensing partnership with Recursion through November 2029Tempus extended its multi-year data license partnership with Recursion through November 2029.Deal resets original master a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL8vkn23:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4539","BK4548","BK4609","BK4611","TEMT","LU1861558580.USD","LU1861559042.SGD","RXRX","BK4139","BK4121","BK4613","TEM","HEAL","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669161540","title":"Tempus AI, Recursion Extend Data License, Amend Fee Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669161540","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669161540?lang=en_us&edition=fundamental","pubTime":"2026-09-21 22:36","pubTimestamp":1790001417,"startTime":"0","endTime":"0","summary":"Tempus AI  and Recursion Pharmaceuticals  extended their data license agreement through November 2029 and revised the contract's fee structure.Up to $84 million in discretionary payments over the next two years will be replaced with $42 million in committed payments over three years, Tempus said Monday in a statement.Tempus said it also signed a separate agreement granting the company a nonexclusive, worldwide license to Recursion's proprietary RNA sequencing model.Tempus shares rose 1.8% in Monday trading, and Recursion climbed 2.6%.Price: 79.27, Change: +1.43, Percent Change: +1.83","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4121","BK4609","BK4611","HEAL","TEMC","BK4539","TEMT","TEM","RXRX","LU1861559042.SGD","LU1861558580.USD","BK4139","BK4613","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169510","title":"Pharma Sector Doubles Down on AI to Slash Costs, Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169510?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:50","pubTimestamp":1789998651,"startTime":"0","endTime":"0","summary":"FACTBOX-Pharma sector doubles down on AI to slash costs, timelinesSept 21 (Reuters)-Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and development,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0WW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL","BMED","03165","TMED","FTEC","VT","MSFT","NVDY","NVDA","NVDS","JGRO","INCY","PAWZ","TEK","PFE","TTEQ","ILDR","LH","HEAL","VGT","NVDU","NVDX","RSPS","ILMN","ANV","TYLG","TMO","TRUH","KD","NVD","NVDG","RNAM","ARTY","TTXU","IQV","VOX","BMY","NVDD","NVII","MRK","KVUE","OZEM","VHT","AZN.UK","ROM","NULC","NVDL","ABBV","NVDQ","GOOGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169875","title":"Recursion, Tempus Expand AI and RNA Collaboration Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169875?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:29","pubTimestamp":1789997370,"startTime":"0","endTime":"0","summary":"The latest update is out from Recursion Pharmaceuticals ( ($RXRX) ). On September 15, 2026, Recursion Pharmaceuticals amended its long-term data an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4539","BK4613","LU1861559042.SGD","BK4548","TEM","TEMC","ARKG","BK4121","BK4611","HEAL","BK4139","LU1861558580.USD","BK4609","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169889","title":"Tempus AI, Recursion extend data license agreement, enter new license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169889?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:20","pubTimestamp":1789996814,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an extension of its data license agreement with Recursion Pharmaceuticals (RXRX). Additionally, the two companies have en...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEMC","BK4121","LU1861559042.SGD","BK4613","BK4539","BK4611","BK4609","ARKG","HEAL","RXRX","BK4548","TEMT","TEM","LU1861558580.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669666681","title":"Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm","url":"https://stock-news.laohu8.com/highlight/detail?id=2669666681","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669666681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARKG","BK4611","LU1861558580.USD","HEAL","TEMC","BK4609","LU1861559042.SGD","RXRX","BK4139","BK4548","BK4613","BK4539","TEM","TEMT","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166574","title":"Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166574?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEMC","LU1861559042.SGD","BK4611","BK4139","BK4548","BK4539","RXRX","BK4613","BK4121","HEAL","ARKG","TEM","TEMT","BK4609","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}